DOI QR코드

DOI QR Code

Korean Pharmacogenomic Database: Pharmacogenomic Haplotype Analysis of the Korean Population and Ethnic Comparisons

  • Kang, Tae-Sun (Department of Pharmacological Research, National Institute of Toxicological Research) ;
  • Woo, Sun-Wook (Department of Pharmacological Research, National Institute of Toxicological Research) ;
  • Park, Hyun-Joo (Department of Pharmacological Research, National Institute of Toxicological Research) ;
  • Roh, Jae-Sook (Department of Obstetrics & Gynecology, College of Medicine, Hanyang University)
  • Published : 2008.06.30

Abstract

The major aim of the Korean Pharmacogenomic Database (KPD) is to offer to users a "bridging" function, making the search for useful information easier. This database has also been established to collect unique Korean genotype data from other databases and to directly link these data to other major databases that offer more informative data. In this way, searches for information about new drug developments and easier and faster evaluation of the more complex and larger databases are possible. The KPD is located at the National Institute of Toxicological Research homepage (http://www.nitr.go.kr/nitr/contents/m134700/view.do), and offers Korean single-nucleotide polymorphism (SNP) information for 154 genes and haplotype information. It also compares the Korean SNP and haplotype frequencies with those of the other ethnic groups registered in the International HapMap. Through the Pharmacogenomic Information and Education facility, we also provide evaluators and the public with information about the concept of pharmacogenomic information, research trends, and the drug regulations of other countries. Because the drug responses of Koreans are not necessarily the same as those of Chinese or Japanese people, it is expected that the systematic operation of the KPD will allow the definition of racial differences and various genomic biomarkers (haplotypes or SNPs) for use in bridging studies and in the approval of new drugs.

Keywords

References

  1. Ardlie, K. G., Kruglyak, L. and Seielstad, M. (2002) Patterns of linkage disequilibrium in the human genome. Nature Reviews Gentics. 3, 299-309 https://doi.org/10.1038/nrg777
  2. Barrett, J. C., Fry, B., Maller, J. and Daly, M. J. (2005). HAPLOVIEW : analysis and visualization of LD and haplotype maps. Bioinformatics. 21, 263-265 https://doi.org/10.1093/bioinformatics/bth457
  3. Caroline, F. T., Teri, E. K. and Russ, B. A. (2005). The Pharmacogenetics and Pharmacogenomics Knowledge Base. In Pharmacogenomics Methods and Protocols (Federico Innocenti, Ed.), pp. 179-191. HUMANA Press
  4. Lee, J. K. and Han, H. L. (2006). Linkage disequilibrium and HapMap. In Genetic Variation and Diseases (J. K. Lee, Ed.), pp. 70-89. Worldscience
  5. Tang, S. W. and Helmeste, D. M. (2002). WWW Bioinformatics Resources. In Pharmacogenomics (Werner Kalow, Urs A. Meyer and Rachel F. Tyndale, Ed.), pp. 493-514. Taylor & Francis
  6. Thorisson, G. A., Smith, A. V., Krishnan, L. and Stein, L.D. (2005). The International HapMap Project Web site. Genome Res. 15, 1592-1593 https://doi.org/10.1101/gr.4413105
  7. Wheeler, D. L., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., Chetvernin, V., Church, D. M., Dicuccio, M., Edgar, R., Federhen, S., Feolo, M., Geer, L. Y., Helmberg, W., Kapustin, Y., Khovayko, O., Landsman, D., Lipman, D. J., Madden, T. L., Maglott, D. R., Miller, V., Ostell, J., Pruitt, K. D., Schuler, G. D., Shumway, M., Sequeira, E., Sherry, S. T., Sirotkin, K., Souvorov, A., Starchenko, G., Tatusov, R. L., Tatusova, T. A., Wagner, L. and Yaschenko, E. (2005). Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 33, 39-45